glp 1 and parkinson's disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes obesity, including cardiovascular and neurodegenerative disorders A Big Week for GLP-1

In a mouse model of left anterior descending coronary artery ligation, SMI administration improved the ejection fraction and fractional shortening

This disease most often occurs due to inadequately treated strep throat or scarlet fever and affects children from 5 to 15 years of age

They reduce appetite and help you feel full

Those with specific goals like supporting detoxification, improving skin glow, or strengthening the immune system

81721003), the Guangdong Province Science & Technology Plan (2014B020228002), the National Key Basic Research and 973 Development Program of China (2015CB964600) and Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program